| Lipid Composition for APG-201 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.84 | 70 |
| Cholesterol | 0.17 | 30 |
| Total | 1.01 mg/vial | 100 |
| Lipid Composition for APG-202 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.72 | 60 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.12 | 10 |
| Cholesterol | 0.17 | 30 |
| Total | 1.01 mg/vial | 100 |
| Lipid Composition for APG-203 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.60 | 50 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.24 | 20 |
| Cholesterol | 0.17 | 30 |
| Total | 1.01 mg/vial | 100 |
| Lipid Composition for APG-204 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.48 | 40 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.35 | 30 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-205 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.36 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.47 | 40 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-206 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.24 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.59 | 50 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-207 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.12 | 10 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.71 | 60 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-208 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.06 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.77 | 65 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-209 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.03 | 2.5 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.80 | 67.5 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
| Lipid Composition for APG-210 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.01 | 1 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.81 | 69 |
| Cholesterol | 0.17 | 30 |
| Total | 0.99 mg/vial | 100 |
| Lipid Composition for APG-211 | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.01 | 0.5 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.82 | 69.5 |
| Cholesterol | 0.17 | 30 |
| Total | 1.00 mg/vial | 100 |
